Scripps Center for Mass Spectrometry and Metabolomics

Scripps Center for Mass Spectrometry and Metabolomics

The Scripps Center for Mass Spectrometry and Metabolomics operates within The Scripps Research Institute, a non-profit biomedical research organization headquartered in La Jolla, California. Founded as a specialized mass spectrometry facility, the center under director Gary Siuzdak has become a global reference for metabolomics methodology — particularly untargeted metabolomics, the broad-spectrum analysis of small molecules in biological samples. The center's core work involves developing and applying mass spectrometry and nuclear magnetic resonance technologies to profile metabolites, lipids, and other small molecules. It offers fee-for-service analysis, collaborates with academic and pharmaceutical partners on drug metabolism and biomarker discovery, and supports research at Scripps and externally. Known platforms include the METLIN metabolite database, curated and maintained by the center, which aggregates tandem mass spectrometry data for over 1.6 million molecular standards. Geographic reach is primarily domestic through collaborations, though METLIN and publications serve a global user base. No verifiable data exists on total expenditures, annual budget, or professional headcount. The center is funded through The Scripps Research Institute's grants and contracts, including from the National Institutes of Health. No adjacent investment vehicles, philanthropic arms, or operating businesses are reported. The unique structural characteristic of the center is its hybrid role as both an internal research core facility for Scripps scientists and a public resource that maintains and distributes a widely-used metabolomics database. It functions as an academic service center, not a financial entity, which distinguishes it from the usual profile of institutional allocators or family offices.